BE900564A - Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. - Google Patents

Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.

Info

Publication number
BE900564A
BE900564A BE0/213641A BE213641A BE900564A BE 900564 A BE900564 A BE 900564A BE 0/213641 A BE0/213641 A BE 0/213641A BE 213641 A BE213641 A BE 213641A BE 900564 A BE900564 A BE 900564A
Authority
BE
Belgium
Prior art keywords
treatment
pharmaceutical composition
peripheral arteriopathies
peripheral
arteriopathies
Prior art date
Application number
BE0/213641A
Other languages
English (en)
French (fr)
Inventor
O N Ulutin
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Publication of BE900564A publication Critical patent/BE900564A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BE0/213641A 1983-09-12 1984-09-12 Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. BE900564A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22855/83A IT1170214B (it) 1983-09-12 1983-09-12 Composizione farmaceutica per la cura delle arteriopatie periferiche

Publications (1)

Publication Number Publication Date
BE900564A true BE900564A (fr) 1985-01-02

Family

ID=11201215

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213641A BE900564A (fr) 1983-09-12 1984-09-12 Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.

Country Status (8)

Country Link
US (1) US5081109A (enExample)
EP (1) EP0137543B1 (enExample)
JP (1) JPH0647545B2 (enExample)
AT (1) ATE55695T1 (enExample)
BE (1) BE900564A (enExample)
CH (1) CH661870A5 (enExample)
DE (1) DE3433328A1 (enExample)
IT (1) IT1170214B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US6699985B2 (en) * 1991-08-21 2004-03-02 Arsinur Burcoglu Method of treating HIV infection and related secondary infections thereof
DE19610345C1 (de) 1996-03-18 1997-11-20 Krupp Vdm Gmbh Katalysator zur Oxidation von Abwasserverunreinigungen mittels Persäuren und/oder Wasserstoffperoxid
HK1044896A1 (zh) * 1997-04-28 2002-11-08 Burcoglu Arsinur 治疗hiv感染和与之有关的继发感染的方法
ITMI20031714A1 (it) * 2003-09-05 2005-03-06 Gentium Spa Formazioni ad azione antitumorale.
CA2598072C (en) * 2005-03-03 2016-05-03 Massimo Iacobelli Formulations with anti-tumour action
SI1891952T1 (sl) * 2006-05-04 2012-02-29 Lek Pharmaceuticals, D.D. Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP1982722A1 (en) * 2007-04-16 2008-10-22 Gentium S.p.A. Use of oligotide for the treatment of renal diseases
EP2103689A1 (en) 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
EP2637672B1 (en) 2010-11-12 2018-08-22 Gentium S.r.l. Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd).
DK2864496T4 (da) 2012-06-22 2021-01-04 Gentium S R L Euglobulin-baseret fremgangsmåde til bestemmelse af den biologiske aktivitet af defibrotid
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
MX2020001337A (es) 2017-08-03 2020-09-09 Jazz Pharmaceuticals Ireland Ltd Formulaciones que comprenden un acido nucleico en una alta concentracion.
KR20210008478A (ko) 2018-04-12 2021-01-22 재즈 파마슈티칼즈, 인코포레이티드 면역고갈과 관련된 사이토카인 방출 증후군 및 신경독성의 예방 및 치료를 위한 데피브로타이드
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (en) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
WO2021212055A1 (en) 2020-04-17 2021-10-21 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
WO2022234101A1 (en) 2021-05-06 2022-11-10 Jazz Pharmaceuticals Ireland Limited Defibrotide for the treatment and prevention of acute respiratory distress syndrome

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) * 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
US4485105A (en) * 1978-10-12 1984-11-27 American Cyanamid Company Method of treating hyperlipidemia with 4-(monoalkylamino)benzoic acid amides
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
US4416877A (en) * 1979-02-13 1983-11-22 Symphar S.A. Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds
JPS5675474A (en) * 1979-11-22 1981-06-22 Chugai Pharmaceut Co Ltd Nicotinamide derivative and medicine containing the same
US4351950A (en) * 1980-01-02 1982-09-28 Warner-Lambert Company Anti-arteriosclerotic agents
US4450272A (en) * 1982-05-06 1984-05-22 American Cyanamid Company Antiatherosclerotic 1-piperazine-thicarboxamides
IT1167197B (it) * 1983-07-25 1987-05-13 Bellon Roger Schoum Rbs Pharma Impiego della fenpiramina quale farmaco antiaggregante piastrinico,vasodilatatore,antitrombotico e antianginoso
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.

Also Published As

Publication number Publication date
EP0137543A2 (en) 1985-04-17
EP0137543A3 (en) 1987-09-02
JPH0647545B2 (ja) 1994-06-22
IT8322855A0 (it) 1983-09-12
DE3433328A1 (de) 1985-03-28
IT1170214B (it) 1987-06-03
ATE55695T1 (de) 1990-09-15
DE3433328C2 (enExample) 1993-08-05
EP0137543B1 (en) 1990-08-22
JPS6169722A (ja) 1986-04-10
US5081109A (en) 1992-01-14
CH661870A5 (it) 1987-08-31

Similar Documents

Publication Publication Date Title
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
BE901737A (fr) Composition pharmaceutique pour le traitement de l'ischemie myocardique aigue.
CA2191129A1 (fr) Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine
CA2330500A1 (fr) Compositions pharmaceutiques gelifiables
BE853086A (fr) Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
EP0963200A4 (en) METHOD AND MEANS FOR INHIBITING ANGIOGENESIS
PT902789E (pt) Derivados de androsteno
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
RU93004793A (ru) Производные хиназолина, способ их получения, фармацевтическая композиция на их основе
OA06533A (fr) Dérivés de la pyrimidine, procédés pour leur préparation, compositions pharmaceutiques contenant ces composés et leur utilisation thérapeutique.
BE900563A (fr) Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue.
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
KR890001564A (ko) 약학적 투여 단위
BE891639A (fr) Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine
KR950016760A (ko) 치질 치료제
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
RU95109891A (ru) 19,11-перекрытые мостиками 4-эстрены, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения для их получения

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: CRINOS INDUSTRIA FARMACOBIOLOGICA S.P.A.

Effective date: 19970930